Initiates cell line development for lead BiTAC-TCE program with ATUM; Stable clonal cell line generation to support CMC development and nonc
VERAXA Biotech AG engaged ATUM to apply Leap-In Transposase technology to support stable clonal cell line generation for its lead BiTAC-T-cell engager (BiTAC-TCE) program - The generated clonal cell lines are intended for use throughout CMC development, including early process, analytical, and formulation development,